NeoProteomics (Sweden) is Biotechnology in Sweden that focus on early diagnosis business. Founded in 2000. They cover business area such as developer, biomarker, sensitive and risk-free cancer diagnosis, platelet role, its user, various form, aggressive cancer, early diagnosis.
2000
( 24 years old in 2024 )
Early Diagnosis
-
Karolinska Sjukhuset / KI, Z5:2
171 76 Stockholm
Sweden
Private
developerbiomarkersensitive and risk-free cancer diagnosisplatelet roleits uservarious formaggressive cancerearly diagnosis
* We use standard office opening hours in near NeoProteomics (Sweden)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NeoProteomics (Sweden) is Biotechnology business from Sweden that founded in 2000 (24 years old in 2024), NeoProteomics (Sweden) business is focusing on Early Diagnosis.
NeoProteomics (Sweden) headquarter office and corporate office address is located in Karolinska Sjukhuset / KI, Z5:2 171 76 Stockholm Sweden.
NeoProteomics (Sweden) was founded in Sweden.
In 2024, NeoProteomics (Sweden) is currently focus on early diagnosis sector.
Above is snippet of Google Trends for "early diagnosis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NeoProteomics (Sweden), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
